{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:47:47Z","timestamp":1791074867772,"version":"4.1.0"},"reference-count":24,"publisher":"Japanese Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2008]]},"DOI":"10.1538\/expanim.57.111","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T05:53:46Z","timestamp":1208757226000},"page":"111-121","source":"Crossref","is-referenced-by-count":67,"title":["Diabetes-Associated Complications in Spontaneously Diabetic Torii Fatty Rats"],"prefix":"10.1538","volume":"57","author":[{"given":"Kenichi","family":"MATSUI","sequence":"first","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"OHTA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"ODA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"SASASE","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"UEDA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"MIYAJIMA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, Toxicology Research Laboratories"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"MASUYAMA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, Toxicology Research Laboratories"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"SHINOHARA","sequence":"additional","affiliation":[{"name":"CLEA Japan Inc., Scientific Research Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuyoshi","family":"MATSUSHITA","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00836.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hoshi, S., Shu, Y., Yoshida, F., Inagaki, T., Sonoda, J., Watanabe, T., Nomoto, K., and Nagata, M. 2002. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab. Invest. 82: 25-35.","DOI":"10.1038\/labinvest.3780392"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.9.1205"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.30.12.1045"},{"key":"5","unstructured":"5. Inomat, S., Haneda, M., Moriya, T., Katayama, S., Iwamoto, Y., Sakai, H., Tomino, Y., Matsuo, S., Asano, Y., and Makino, H. 2005. Revised criteria for the early diagnosis of diabetic nephropathy. Nippon Jinzo Gakkai Shi 47: 767-769."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-005-0188-9"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.38.2.159"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00548-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Masuyama, T., Katsuda, Y., and Shinohara, M. 2005. A novel model of obesity-related diabetes: introgression of the Lepr(fa) allele of the Zucker fatty rat into nonobese Spontaneously Diabetic Torii (SDT) rats. Exp. Anim. 54: 13-20.","DOI":"10.1538\/expanim.54.13"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.39.2.245"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsui, H., Suzuki, M., Tsukuda, R., Iida, K., Miyasaka, M., and Ikeda, H. 1996. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Diabetes Res. Clin. Pract. 32: 1-9.","DOI":"10.1016\/0168-8227(96)01209-0"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.3109\/00365518609083660"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.85.416"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ohta, T., Matsui, K., Miyajima, K., Sasase, T., Masuyama, T., Shoda, T., Koizumi, H., Shinohara, M., and Matsushita, M. 2007. Effect of insulin therapy on renal changes in Spontaneously Diabetic Torii rats. Exp. Anim. 56: 355-362.","DOI":"10.1538\/expanim.56.355"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sasase, T. 2006. PKC-a target for treating diabetic complications. Drugs Fut. 31: 503-511.","DOI":"10.1358\/dof.2006.031.06.997160"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00535.x"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705884"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Segawa, M., Hirata, Y., Fujimori, S., and Okada, K. 1988. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia. Metabolism 37: 454-460.","DOI":"10.1016\/0026-0495(88)90046-7"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703328"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1155\/EDR.2000.89"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Smith, S.A., Lister, C.A., Toseland, C.D., and Buckingham, R.E. 2000. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Diabetes Obes. Metab. 2: 363-372.","DOI":"10.1046\/j.1463-1326.2000.00099.x"},{"issue":"1","key":"22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1507\/endocrj1954.36.65","volume":"36","author":"SUGIYAMA Y","year":"1989","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Vora, J.P., Zimsen, S.M., Houghton, D.C., and Anderson, S. 1996. Evolution of metabolic and renal changes in the ZDF\/Drt-fa rat model of type II diabetes. J. Am. Soc. Nephrol. 7: 113-117.","DOI":"10.1681\/ASN.V71113"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yoshimoto, T., Naruse, M., Nishikawa, M., Naruse, K., Tanabe, A., Seki, T., Imaki, T., Demura, R., Aikawa, E., and Demura, H. 1997. Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats. Am. J. Physiol. 272: E989-996.","DOI":"10.1152\/ajpendo.1997.272.6.E989"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/expanim\/57\/2\/57_2_111\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:58:25Z","timestamp":1631116705000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/expanim\/57\/2\/57_2_111\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.57.111","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}